Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Flash glucose monitoring now covered for adults in the Yukon, but coverage for continuous glucose monitoring ends

UPDATE – October 1: Yukon will fund CGM for adults. This follows announcement last month to fund Flash GM.

September 25, 2020

The Yukon government has made the decision to fully fund flash glucose monitors (FGMs) for those 18 years of age and older with type 1 diabetes (T1D) starting on October 1st. While this expansion of access to T1D technologies is a step in the right direction, the decision was made after ending a pilot program that covered continuous glucose monitors (CGMs) for those 18-25 years old.

Improving access to advanced glucose monitoring for everyone living with T1D is the goal of JDRF’s Access for All campaign. Patients should have the choice of which device to use – whether it is CGM or FGM – that is most effective in managing their disease and this decision should not be based on which devices are publicly funded. Technology cannot be approached as one size fits all because each device has its own benefits and the best option will vary from person to person based on their circumstances and needs. For example, for someone with hypo unawareness, extra protection is provided by alarms offered on a CGM that alert the wearer of high or low blood sugar levels, including while sleeping, and allow them to take quick action.

The government’s plan will allow adults to be reimbursed up to the maximum cost of the FGM if they prefer to opt for a CGM instead. However, this will still pose a financial burden for some.

Public funding for T1D technologies continues to be an issue in provinces across Canada and JDRF is committed to working with the T1D community and provincial governments to get to our end goal of Access for All.

To learn more about JDRF’s #AccessForAll campaign check out breakthrought1d.ca/accessforall.

Sign up for our newsletter and stay connected